Introducing InnovaCare’s CEO Dr. Rick Shinto and COO Penelope Kokkinides

Headquartered in Fort Lee New Jersey, InnovaCare provides access to quality affordable healthcare to people in Puerto Rico. The company’s use of technology is the reason they can provide affordable care. Seventy-percent of Puerto Ricans choose InnovaCare over traditional insurance companies.

In 2012 Dr. Richard Shinto took the helm as InnovoCare’s CEO. A pulmonologist by training Dr. Shinto’s MD was earned at the University of New York. He has also earned a Bachelor of Science from the University of California and a Master of Business Administration from Redlands University.

He has held leadership positions at Aveta Inc. where he served as CEO. While at Aveta Dr. Rick Shinto was honored with the Ernst & Young Entrepreneur Of The Year Award. Dr. Shinto’s innovations, fiscal management, and community involvement garnered him the award.

He left Aveta for InnovaCare. Before joining Aveta Dr. Richard Shinto was Pathways Management Company’s Chief Medical Officer and CEO. For more details visit Bloomberg.

Regarded as a leader who motivates others Dr. Shinto predicts that going forward InnovaCare will expand the list of services available to their clients. His innovations are credited with the success InnovaCare has enjoyed over the last six years. Check out

The Health Care Payment Learning and Action Network (LAN)seeks to reduce healthcare cost by basing them on quality rather than quantity. In August of 2016, Innovacare became a member of LAN as part of its efforts to provide cost-effective quality care.

After serving as COO and Vice President of Clinical Operations at InnovaCare Penelope Kokkinides became the company’s COO In June of 2015. She has two decades of experience in healthcare, Medicare/ Medicaid, and managed care.

Penelope came to InnovoCare from Centerlight Healthcare where she was the CEO and executive vice president. She has also served as CEO of Touchstone Health.

As AmeriChoice’s vice president for care and disease management, Penelope played a key role in the development of the company’s health model. Her area of expertise is making managed healthcare more efficient.

Educated at Binghamton University Penelope studied biological sciences and classical languages. She left BU with a Bachelor’s Degree in both. Her Master’s Degree in Public Health is from Columbia University School of Public Health.

She holds a Master’s Degree in Social Work from New York University. While at NYU she did post master’s degree work in alcohol and substance abuse Columbia University School of Public Health is where Penelope received a Master’s in Public Health.

Click here:

Cancer Treatment Centers Of America Launches Innovative Partnership

Cancer Treatment Centers of America (CTCA) is a network of five hospitals that provides cancer treatment across the nation. The organization recently announced a partnership with Allscripts and NantHealth will result in a solution that will streamline the treatment of cancer while not inhibiting the doctor’s clinical workflow. The products and services that will be involved in NantHealth’s eviti which is a clinical decision support platform and Sunrise Electronic Health Record which is supplied by Allscripts.
The Chief Medical Officer of CTCA is Dr. George Daneker, Jr. who works at the Southeastern Regional Medical Center. Dr. Daneker said that this partnership, called Clinical Pathways, will present physicians with all of the cancer treatment options that are appropriate for a particular patient. He also said that this will result in less educated guesswork and help them provide therapies and drugs that are safe and efficient.
According to Wikipedia, CTCA is based in Boca Raton, Florida. It has five hospitals that are strategically located across the continental United States in every region. The organization uses conventional approaches to cancer treatment such as chemotherapy, surgery, immunotherapy, and radiation. Additionally, the doctors at CTCA use therapies to treat the side effects of cancer treatment such as nausea, fatigue, depression, and pain.
Cancer Treatment Centers of America blog was founded in 1988 in order to provide a patient-focused approach to cancer treatment that could be modified to fit the individualized needs of each patient. All of the Oncologists at CTCA are board-certified and have specialists in every type of cancer including breast, prostate, cervical, lung, and all of forms of cancer. The founder of the organization was Richard J. Stephenson who had lost his mother to cancer. He discovered during her therapy that there weren’t very good treatment options available and so founded his company in order to offer other patients better rates of survivability.

For further information on CTCA follow them on Facebook and Twitter.

The entrepreneur – Eric Lefkofsky

Eric P. Lefkofsky is an American entrepreneur, born in Detroit, Michigan, in September 1969. Among other things, he is co-founder and Chief Executive Officer of Tempus. He is Jewish and grew up in Southfield, Michigan. Eric Lefkofsky attended the University Of Michigan and graduated in 1991. He proceeded on at University Of Michigan Law School to receive his JD in 1993. Eric Lefkofsky is now a Trustee at Lurie Children’s Hospital of Chicago, and he is a member of The Giving Pledge and committed to donate half of his wealth over his lifetime to philanthropy.


Eric Lefkofsky motivation for starting Tempus was personal. He watch a family member actually being treated inside a clinical setting. And he realized how critical it was to bring technology to the very physicians that were seeing patients everyday. Tempus is a health-tech company that facilitate physician to deliver individualize treatment care. Their goal is to live in a world where each patient benefits from the treatment based on the data and knowledge aggregate of all the other patients who have come before him or her. That is what Tempus is delivering, as they can now gather genomic data, allowing physician to make decision while treating patients that could improve patient outcomes. In other words, is a platform or operating system to help physicians in clinic, while treating patients, analyze incredible amounts of data that is specific to a patient and make real-time decisions. This allow Tempus to now have the ability, in a personalize manner, to provide real hope.


What makes Tempus’ approach so uniquely innovative is their software platform. The challenges of trying to cut through all kinds of information is miniaturized. To bring genomic data into clinical care, Tempus combined the molecular data with the phenotypic data, and that combination of data will allow for powerful decisions.


This is a new and exciting era in modern medicine with Tempus.


Find out more here on